Vef Management III LLC insider trades: Vitae Pharmaceuticals (VTAE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vef Management III LLC reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 29, 2014 | VTAE | ↑ Buy | 772,333 | $8.00 | $6.2M | Indirect | Oct 1, 2014 (2d) |
| Nov 20, 2012 | VCRA | ↓ Sell | 14,000 | $24.96 | $349K | By Funds and LLC | Nov 21, 2012 (1d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 153,369 | $18.00 | $2.8M | By Funds | Nov 9, 2011 (0d) |
| Jul 6, 2005 | RNAI | ↑ Buy | 24,999 | $1.60 | $40K | By Fund | Jul 8, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Vef Management III LLC's insider trades
Vef Management III LLC is a 10% owner of Vitae Pharmaceuticals (VTAE). Since Jul 6, 2005, it has reported 3 open-market purchases worth $9.0M and 1 sale worth $349K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (5 filings), conversions (4 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VTAE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.